Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 12, 1998, Pages 4350-4354

  Cordido, Fernando ^a,b   Fernandez, Teresa ^a   Martinez, Teresa ^a   Peñalva, Angela ^c   Peinó, Roberto ^c   Casanueva, Felipe F ^c   Dieguez, Carlos ^c  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b UNIVERSITY OF A CORUÑA   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACIPIMOX; CORTICOSTEROID; FATTY ACID; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; PRALMORELIN; STEROID; THYROXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EMPTY SELLA SYNDROME; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FEMALE; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HORMONAL THERAPY; HORMONE RESPONSE; HUMAN; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; INSULIN TOLERANCE TEST; INTRAVENOUS DRUG ADMINISTRATION; MALE; OBESITY; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; PROLACTINOMA;

EID: 0032462257     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.12.4350     Document Type: Article

References (28)

1. 1. Kopelman PG, Noonan K. 1987 Growth hormone response to low dose intravenous injections of growth hormone releasing factor in obese and normal weight women. Clin Endocrinol (Oxf). 27:727-733.
2. 2. Loche S, Pintor C, Cappa M, et al. 1989 Pyridostigmine counteracts the blunted growth hormone response to growth hormone-releasing hormone of obese children. Acta Endocrinol (Copenh). 120:624-628.
3. 3. Cordido F, Casanueva FF, Dieguez C. 1989 Cholinergic receptor activation by pyridostigmine restores GH responsiveness to GH-releasing hormone administration in obese subjects. J Clin Endocrinol Metab. 68:290-293.
4. 4. Williams T, Berelowitz M, Joffe SN, et al. 1984 Impaired growth hormone responses to growth hormone-releasing factor in obesity. N Engl J Med. 311:1403-1407.
5. 5. Kelijman M, Frohman LA. 1988 Enhanced growth hormone responsiveness to GH releasing hormone after dietary manipulation in obese and non-obese subjects. J Clin Endocrinol Metab. 66:489-494.
6. 6. Cordido F, Peinó R, Peñalva A, Alvarez CV, Casanueva FF, Dieguez C. 1996 Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression. J Clin Endocrinol Metab. 81:914-918.
7. 7. Maccario M, Procopio M, Grottoli S, et al. 1996 Effects of acipimox, an antylipolytic drug, on the growth hormone response to GH-releasing hormone alone or combined with arginine in obesity. Metabolism. 45:342-346.
8. 8. Andreotti AC, Lanzi R, Manzoni MF, Caumo A, Moreschi A, Pontiroli AE. 1994 Acute pharmacologic blockade of lypolisis normalizes nocturnal growth hormone levels and pulsatility in obese subjects. Metabolism. 43:1207-1213.
9. 9. De Boer H, Blok G-J, Van der Veen E. 1995 Clinical aspects of growth hormone deficiency in adults. Endocr Rev. 16:63-86.
10. 10. Salomon F, Cuneo RC, Hesp R, Sönksen PH. 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 321:1797-1803.
11. 11. Jorgensen JOL, Pedersen SA, Thuesen L, et al. 1989 Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet. 1:1221-1225.
12. 12. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, Lizarralde G. 1991 Dual defects in pulsatile GH secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab. 72:492-495.
13. 13. Dieguez C, Casanueva FF. 1995 Influence of metabolic substrates and obesity on growth hormone secretion. Trends Endocrinol Metab. 6:55-59.
14. 14. Massara F, Ghigo E, Molinati P, et al. 1986 Potentiation of cholinergic tone by pyridostigmine bromide re-instates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone releasing factor in man. Acta Endocrinol (Copenh). 113:12-16.
15. 15. Peñalva A, Muruais C, Casanueva FF, Dieguez C. 1990 Effect of enhancement of endogenous cholinergic tone with pyridostigmine on the dose-response relationships of growth hormone-releasing hormone-induced growth hormone secretion in man. J Clin Endocrinol Metab. 70:324-328.
16. 16. Cordido F, Dieguez C, Casanueva FF. 1990 Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine or hypoglycemia in normal and obese subjects. J Clin Endocrinol Metab. 70:1361-1370.
17. 17. Nam SY, Lee EJ, Kim KR, et al. 1996 Long-term administration of acipimox potentiates growth hormone response growth hormone-releasing hormone by decreasing serum free fatty acid in obesity. Metabolism. 45:594-597.
18. 18. Thorner MO, Bengtsson B-A, Ho KY, et al. 1995 The diagnosis of growth hormone deficiency in adults. J Clin Endocrinol Metab. 80:3097-3098.
19. 19. Toogood AA, Colin G, Beardwell CG, Shalet SM. 1994 The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism. Clin Endocrinol (Oxf). 41:511-516.
20. 20. Borges JLC, Gelato MC, Rogol AD, et al. 1983 Effects of human pancreatic tumor growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiency. Lancet. 2:119-123.
21. 21. Ho KKY, Hoffman DM. 1995 Defining growth hormone deficiency in adults. Metabolism. [Suppl 4] 44:91-96.
22. 22. Baum HBA, Biller BMK, Katznelson L, et al. 1996 Assessment of GH secretion in men with adult-onset GH deficiency compared with that in normal men-A clinical research center study. J Clin Endocrinol Metab. 81:84-92.
23. 23. Moreira-Andres MN, Canizo FJ, Hawkins F. 1993 Is there a place for urinary growth hormone measurement?. Acta Endocrinol (Copenh). 128:197-201.
24. 24. Hoffman DM, O'Sullivan AJ, Baxter RC, Ho KKY. 1994 Diagnosis of growth hormone deficiency in adults. Lancet. 343:1064-1068.
25. 25. Bengtsson B-A, Edén S, Lönn L, et al. 1993 Treatment of adults with GH deficiency with recombinant human GH. J Clin Endocrinol Metab. 76:309-317.
26. 26. Hoeck HC, Vestergoard P, Jakobson PE, Laurberg P. 1995 Test of growth hormone secretion in adults: poor reproducibility of the insulin tolerance test. Eur J Endocrinol. 133:305-312.
27. 27. Shah A, Stanhope R, Matthew D. 1992 Hazards of pharmacological tests of growth hormone secretion in childhood. Br Med J. 304:173-174.
28. 28. Vierhapper H, Nowotny P, Czech T, Bieglmayer C, Raber W, Waldhäusl W. 1997 How (not) to diagnose growth hormone deficiency in adults: stimulated serum concentrations of growth hormone in healthy subjects and in patients with pituitary macroadenomas. Metabolism. 46:680-683.